The Effects of Vegetable Preloading on Postprandial Glycemia, Insulinaemia and Gastric Emptying

NCT06640335 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-11-08

No results posted yet for this study

Summary

The objective of this study is to investigate the importance of leavy vegetable preloading on the postprandial glycaemic and insulinemic response in human subjects when consumed a specific amount of digestible carbohydrate from Russet Burbank potatoes source.

Conditions

  • Postprandial Hyperglycemia
  • Insulin High

Interventions

OTHER

Co-ingestion

Subjects co-ingest both (300 g mashed potatoes) and (200 g baby round spinach supplemented with canola oil) in the same time.

OTHER

0 min preload

Subjects consume 200 g baby round spinach supplemented with canola oil first, then directly consume 300 g of mashed potatoes.

OTHER

5 min preload

Subjects consume 200 g baby round spinach supplemented with canola oil first, wait 5 minutes, then consume 300 g of mashed potatoes.

OTHER

10 min preload

Subjects consume 200 g baby round spinach supplemented with canola oil first, wait 10 minutes, then consume 300 g of mashed potatoes.

OTHER

15 min preload

Subjects consume 200 g baby round spinach supplemented with canola oil first, wait 15 minutes, then consume 300 g of mashed potatoes.

OTHER

20 min preload

Subjects consume 200 g baby round spinach supplemented with canola oil first, wait 20 minutes, then consume 300 g of mashed potatoes.

OTHER

Spinach only / 10 min preload

Subjects consume 200 g baby round spinach WITHOUT canola oil first, wait 10 minutes, then consume 300 g of mashed potatoes.

OTHER

Canola oil only / 10 min preload

Subjects consume 20 g of canola oil first, wait 10 minutes, then consume 300 g of mashed potatoes.

Sponsors & Collaborators

  • Alliance for Potato Research and Education

    collaborator OTHER
  • Singapore Institute of Food and Biotechnology Innovation

    lead OTHER_GOV

Principal Investigators

  • Amy Lin, PhD · Senior Principal Scientist I at Singapore Institute of Food and Biotechnology Innovation

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2024-11-30
Completion
2025-09-19

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06640335 on ClinicalTrials.gov